Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Candesartan Cilexetil EP Impurity C

Candesartan Cilexetil EP Impurity C is listed in the pharmaceutical impurity collection under CAS 1185255-99-5. Its represented structure has formula C33H34N6O6 and a calculated molecular weight of 610.67 g/mol.

2D chemical structure

N N N N N O N H O O O O O

Chemical identity

Catalog name
Candesartan Cilexetil EP Impurity C
Common name
Candesartan Cilexetil EP Impurity C
Chemical name
1-cyclohexyloxycarbonyloxyethyl 3-[[4-[2-(1-ethyltetrazol-5-yl)phenyl]phenyl]methyl]-2-oxo-1H-benzimidazole-4-carboxylate
CAS
1185255-99-5
SMILES
CCn1nnnc1-c1ccccc1-c1ccc(Cn2c(=O)[nH]c3cccc(C(=O)OC(C)OC(=O)OC4CCCCC4)c32)cc1
InChI
InChI=1S/C33H34N6O6/c1-3-39-30(35-36-37-39)26-13-8-7-12-25(26)23-18-16-22(17-19-23)20-38-29-27(14-9-15-28(29)34-32(38)41)31(40)43-21(2)44-33(42)45-24-10-5-4-6-11-24/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,34,41)
InChIKey
DEGBAMTUFHKMQR-UHFFFAOYSA-N
Associated API
Candesartan Cilexetil

Record ID: A2423dfa43946

Computed properties

C33H34N6O6 Molecular formula
610.671 g/molMolecular weight
610.254 DaMonoisotopic exact mass
143.22 ŲTopological polar surface area
5.707 Calculated LogP (Wildman–Crippen)
165.3402 cm³/molMolar refractivity (Wildman–Crippen)
9 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight610.67192.36
Calculated LogP (Wildman–Crippen)5.70793.69
Topological polar surface area143.2287.84
Hydrogen-bond acceptors991.13
Hydrogen-bond donors138.08
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC33H34N6O6dimensionless
Molecular weight610.671g/mol
Monoisotopic exact mass610.254Da
Topological polar surface area143.22Ų
Calculated LogP (Wildman–Crippen)5.707dimensionless
Molar refractivity (Wildman–Crippen)165.3402cm³/mol
Hydrogen-bond acceptors9count
Hydrogen-bond donors1count
Rotatable bonds (strict)9count
Heavy atoms45count
Heteroatoms12count
Rings6count
Aromatic rings5count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles2count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles3count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.3333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area258.4702Ų
Valence electrons232count
Radical electrons0count
Bertz complexity1,868.664index
Balaban J1.1969index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Candesartan Cilexetil EP Impurity C

Qualification and safety assessment of Candesartan Cilexetil EP Impurity C

Explore toxicological qualification of Candesartan Cilexetil EP Impurity C and ICH M7 mutagenic impurity assessment of Candesartan Cilexetil EP Impurity C for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Candesartan Cilexetil EP Impurity C and acceptable intake and limit justification for Candesartan Cilexetil EP Impurity C. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Candesartan Cilexetil EP Impurity C

Explore Altox services and software through the Altox Pharma-Hub.